(19)
(11) EP 3 893 936 A2

(12)

(88) Date of publication A3:
06.08.2020

(43) Date of publication:
20.10.2021 Bulletin 2021/42

(21) Application number: 19828513.2

(22) Date of filing: 10.12.2019
(51) International Patent Classification (IPC): 
A61K 47/60(2017.01)
A61K 45/06(2006.01)
A61P 31/18(2006.01)
A61K 38/00(2006.01)
A61K 39/00(2006.01)
A61K 31/351(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/60; A61K 47/55; A61K 47/543; A61P 31/18; A61K 47/549; A61K 39/39; A61K 45/06; A61K 2039/5158; A61K 2039/58; A61K 38/00; A61K 31/7036
 
C-Sets:
A61K 31/7036, A61K 2300/00;
(86) International application number:
PCT/US2019/065361
(87) International publication number:
WO 2020/123435 (18.06.2020 Gazette 2020/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.12.2018 US 201862777753 P
13.09.2019 US 201962900164 P

(71) Applicant: GlycoMimetics, Inc.
Rockville, MD 20850 (US)

(72) Inventor:
  • MAGNANI, John L.
    Gaithersburg, Maryland 20878 (US)

(74) Representative: Mathys & Squire 
The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) METHODS OF TREATING HIV AND AIDS AND THE ELIMINATION OF LATENT RESERVOIRS OF HIV INFECTION USING SELECTIN, GALECTIN, AND SIGLEC ANTAGONISTS